CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis - Top-Institutions - MDSpire

CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases

  • March 11, 2026

  • 3 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Max Planck Institute of Biochemistry
    Max Planck Institute of Biochemistry

    Martinsried, Bavaria

    Key Differentiators

    • Proteomics
    • Neurology
    • Multiple Sclerosis

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroproteomics

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, California

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Proteomics

Original Source(s)

CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

  • March 11, 2026

Related Content

Redefining Neuro-Ophthalmology

The eye-brain connection and the future of imaging

Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS

  • February 17, 2026

  • 3 min
The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability